AKT1 and ovarian cancer: Using gain- and loss-of-function strategies, we demonstrated that AMPK-β1 profoundly impairs cell growth, migration and invasion capacities via activating AMPK but attenuating AKT, ERK and JNK activities in advanced ovarian cancer cells.